BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27866327)

  • 21. Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.
    Obermajer N; Popp FC; Soeder Y; Haarer J; Geissler EK; Schlitt HJ; Dahlke MH
    J Immunol; 2014 Nov; 193(10):4988-99. PubMed ID: 25305313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trained murine mesenchymal stem cells have anti-inflammatory effect on macrophages, but defective regulation on T-cell proliferation.
    Lin T; Pajarinen J; Kohno Y; Huang JF; Maruyama M; Romero-Lopez M; Nathan K; Yao Z; Goodman SB
    FASEB J; 2019 Mar; 33(3):4203-4211. PubMed ID: 30521384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: an in-vitro study in healthy humans.
    Fanigliulo D; Lazzerini PE; Capecchi PL; Ulivieri C; Baldari CT; Laghi-Pasini F
    Int Immunopharmacol; 2015 Feb; 24(2):276-284. PubMed ID: 25536542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.
    Heidt S; Roelen DL; Eijsink C; Eikmans M; van Kooten C; Claas FH; Mulder A
    Clin Exp Immunol; 2010 Feb; 159(2):199-207. PubMed ID: 19922499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.
    Poncelet AJ; Nizet Y; Vercruysse J; Hiel AL; Saliez A; Gianello P
    Transplantation; 2008 Dec; 86(11):1586-95. PubMed ID: 19077894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacodynamic assessment of
    Grobman M; Bishop KA; Rindt H; Nafe LA; Reinero CR
    Can J Vet Res; 2019 Oct; 83(4):279-284. PubMed ID: 31571728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences of Clonogenic Mesenchymal Stem Cells on Immunomodulation of Lymphocyte Subsets.
    Martínez-Peinado P; Pascual-García S; Roche E; Sempere-Ortells JM
    J Immunol Res; 2018; 2018():7232717. PubMed ID: 30271793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunomodulatory Effects of Human Adipose Tissue-derived Mesenchymal Stem Cells on T Cell Subsets in Patients with Rheumatoid Arthritis.
    Baharlou R; Rashidi N; Ahmadi-Vasmehjani A; Khoubyari M; Sheikh M; Erfanian S
    Iran J Allergy Asthma Immunol; 2019 Feb; 18(1):114-119. PubMed ID: 30848580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapamycin Combined with Immature Dendritic Cells Attenuates Obliterative Bronchiolitis in Trachea Allograft Rats by Regulating the Balance of Regulatory and Effector T Cells.
    Dong M; Wang X; Liu J; Zhao YX; Chen XL; Li KQ; Li G
    Int Arch Allergy Immunol; 2015; 167(3):177-85. PubMed ID: 26302996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cardiac allograft rejection in mice using interleukin-35-modified mesenchymal stem cells.
    Wang W; Zhao N; Li B; Gao H; Yan Y; Guo H
    Scand J Immunol; 2019 Apr; 89(4):e12750. PubMed ID: 30664805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An in Vitro and in Vivo Study of the Effect of Dexamethasone on Immunoinhibitory Function of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
    Wang D; Sun YQ; Gao WX; Fan XL; Shi JB; Fu QL
    Cell Transplant; 2018 Sep; 27(9):1340-1351. PubMed ID: 30056763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of small molecules immunosuppressants on P-glycoprotein activity and T-cell function.
    Llaudó I; Cassis L; Torras J; Bestard O; Franquesa Ml; Cruzado JM; Cerezo G; Castaño E; Pétriz J; Herrero-Fresneda I; Grinyó JM; Lloberas N
    J Pharm Pharm Sci; 2012; 15(3):407-19. PubMed ID: 22974789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune pancreatitis in MRL/Mp mice is a T cell-mediated disease responsive to cyclosporine A and rapamycin treatment.
    Schwaiger T; van den Brandt C; Fitzner B; Zaatreh S; Kraatz F; Dummer A; Nizze H; Evert M; Bröker BM; Brunner-Weinzierl MC; Wartmann T; Salem T; Lerch MM; Jaster R; Mayerle J
    Gut; 2014 Mar; 63(3):494-505. PubMed ID: 23564336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer.
    Lin R; Ma H; Ding Z; Shi W; Qian W; Song J; Hou X
    Stem Cells Dev; 2013 Nov; 22(21):2836-48. PubMed ID: 23777268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The investigation of immunomodulatory effects of adipose tissue mesenchymal stem cell educated macrophages on the CD4 T cells.
    Özdemir RBÖ; Özdemir AT; Sarıboyacı AE; Uysal O; Tuğlu Mİ; Kırmaz C
    Immunobiology; 2019 Jul; 224(4):585-594. PubMed ID: 31072631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens.
    Li X; Wang Q; Ding L; Wang YX; Zhao ZD; Mao N; Wu CT; Wang H; Zhu H; Ning SB
    Stem Cell Res Ther; 2019 Aug; 10(1):267. PubMed ID: 31443680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes.
    Maccario R; Moretta A; Cometa A; Montagna D; Comoli P; Locatelli F; Podestà M; Frassoni F
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1031-2. PubMed ID: 16338626
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
    Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM
    Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.